Morning Movers 5/6: SBGI, ACOR, ARM, LINC, MPG Higher; ABD, ACAS, ALY, BBND, DENN Lower
Sinclair Broadcast Group (Nasdaq: SBGI) 42.3% HIGHER; reports Q1 adj-EPS of $0.19, versus the analyst estimate of ($0.05). Revenue for the quarter was $131.3 million, versus the consensus of $141.73 million.
Acorda Therapeutics (Nasdaq: ACOR) 28.2% HIGHER; the FDA has accepted the Fampridine-SR New Drug Application for filing, assigning Priority Review and a Prescription Drug User Fee Act date of October 22, 2009. The PDUFA date is the target date for the FDA to complete its review of the Fampridine-SR NDA. Acorda also reported Q1 EPS of $0.50, 5 cents better than the analyst estimate of $0.55. Revenue for the quarter was $12.5 million, versus the consensus of $12.88 million.
ArvinMeritor (NYSE: ARM) 27% HIGHER; reports Q1 loss of $0.65, 3 cents better than the analyst estimate of ($0.68). Revenue for the quarter was $1.1 billion, versus the consensus of $1.24 billion. Click here for the full report.
Lincoln Educational Services (Nasdaq: LINC) 26.8% HIGHER; reports Q1 EPS of $0.22, versus the analyst estimate of $0.06. Revenue for the quarter was $118.6 million, versus the consensus of $112.25 million. Student starts increased by 42.4% as compared to Q108. On a same school basis, student starts increased 35.1% as compared to Q1. Sees Q2 EPS of $0.18-$0.20, on sales of $120-$122 million. The Street is currently looking for Q2 EPS and sales of $0.07 and $112.40 million, respectively. For the year, LINC sees EPS of $1.25-$1.30, versus the consensus of $0.95, with sales of $505-$515 million, which compares to the Street estimate of $482.04 million.
Maguire Properties (NYSE: MPG) 24.1% HIGHER; reports Q1 FFO loss of $0.64, compared to a loss of $0.01 in the same quarter last year. Revenue for the quarter was $ million, versus $ million in Q08.
ACCO Brands (NYSE: ABD) 22.2% LOWER; reports Q1 EPS of ($0.02), versus the analyst estimate of ($0.05). Revenue for the quarter was $293.4 million, versus the consensus of $332 million. Will not provide specific '09 guidance.
Bank of Ireland (NYSE: IRE) 20% HIGHER; European banks are outperforming today as investors continue to hang onto hopes that the worst could be behind us.
Cell Therapeutics (Nasdaq: CTIC) 19.1% HIGHER; following news yesterday that Cell Therapeutics' pixantrone is now available in Europe on a named-patient basis, momentum in the name is continuing today.
Par Pharma (NYSE: PRX) 19.1% HIGHER; reports Q1 EPS of $0.49, ex-items, versus the analyst estimate of $0.27. Revenue for the quarter was $204 million, versus the consensus of $170.23 million.
American Capital, Ltd. (Nasdaq: ACAS) 17.4% LOWER; reports Q1 EPS of $0.31, 6 cents worse than the analyst estimate of $0.37. Revenue for the quarter was $181 million, versus the consensus of $185.8 million.
American Medical Systems Holdings (Nasdaq: AMMD) 17.3% HIGHER; reports Q1 EPS of $0.25, 10 cents better than the analyst estimate of $0.15. Revenue for the quarter was $123.6 million, versus the consensus of $119.66 million. Company has increased its 2009 non-GAAP adjusted earnings per share guidance to a range of $0.96 to $1.07, from its earlier guidance of $0.86 to $0.99 per share. (Consensus is $0.80) The Company reiterates its full year 2009 revenue guidance in the range of $495 million to $515 million. (Consenus is $507.07M) Second quarter revenue is estimated in the range of $124 million to $130 million. (Consensus is $129.57M) The Company estimates second quarter 2009 non-GAAP adjusted earnings per share will be in the range of $0.22 to $0.26. (Consensus is $0.20)
Allied Irish Banks (NYSE: AIB) 16.6% HIGHER; see IRE.
Allis-Chalmers Energy Inc. (NYSE: ALY) 16.5% LOWER; reports Q1 loss of $0.07, 9 cents worse than the analyst estimate of $0.02. Revenue for the quarter was $145.1 million, versus the consensus of $151.10 million.
Fortress (NYSE: FIG) 15.2% HIGHER; reports Q1 loss of $0.71, versus the analyst estimate of ($0.05). Revenue for the quarter was $122.3 million, versus the consensus of $87.31 million.
Crocs (Nasdaq: CROX) 15.2% HIGHER; shares are continuing higher today following yesterday's 42% jump. Click here for the full report.
BigBand Networks (Nasdaq: BBND) 15% LOWER; reports Q1 EPS of $0.09, 4 cents better than the analyst estimate of $0.05. Revenue for the quarter was $43.9 million, versus the consensus of $44.29 million. For the second quarter of 2009 management provides the following outlook: Net revenues are expected to be in the range of $40 million to $42 million vs. consensus of $46.87 million. Non-GAAP net earnings per share are expected to be in the range of $0.02 to $0.04 vs. consensus of $0.06.
Boyd Gaming (NYSE: BYD) 14.9% HIGHER; reports Q1 earnings of $0.15 per share, ex-items, above the consensus of $0.08. Revenues fell 7.7% to $434.8 million, versus the consensus of $435.2 million.
Denny's Corporation (Nasdaq: DENN) 14.9% LOWER; reports Q1 EPS of $0.04, 1 cent worse than the analyst estimate of $0.05. Revenue for the quarter was $165.8 million, versus the consensus of $158.32 million. Based on year-to-date results and management’s expectations at this time, Denny’s is reaffirming its financial guidance for full-year 2009 as announced in its fourth quarter 2008 earnings release on February 18, 2009.
General Motors (NYSE: GM) 14.7% LOWER; downside related to the debt-to-equity swap and the possibly that the automaker could do a 1-for-100 reverse stock split.
Lincoln National (NYSE: LNC) 14.5% HIGHER; reports Q1 EPS of $0.66 including items, 5 cents below the analyst estimate of $0.71.
Biovail Corporation (NYSE: BVF) 13.6% LOWER; reports Q1 EPS of $0.42, 12 cents better than the analyst estimate of $0.30. Revenue for the quarter was $173.3 million, versus the consensus of $176.88 million. Biovail also announced today that it has entered into an agreement to acquire the U.S. commercialization rights to Wellbutrin XL(R) (extended-release bupropion hydrochloride tablets) from GlaxoSmithKline (GSK) for total consideration of $510 million. Also declared a quarterly dividend of $0.09 per share payable on July 6, 2009, to shareholders of record at the close of business May 15, 2009. The ex-dividend date is May 13, 2009. This represents a 76% reduction in the dividend payment.
True Religion Apparel (Nasdaq: TRLG) 12.3% HIGHER; reports Q1 EPS of $0.32, 4 cents better than the analyst estimate of $0.28. Revenue for the quarter rose 19.1% to $63.1 million, versus the consensus of $58.7 million. The Company is reiterating its guidance for the fiscal year ended December 31, 2009: Net sales are expected to be in the range of $290 million to $297 million, EPS is expected to be in the range of $1.73 to $1.81.
Rackable Systems, Inc. (Nasdaq: RACK) 11% LOWER; reports Q1 loss of $0.24, 9 cents worse than the analyst estimate of ($0.15). Revenue for the quarter was $44.4 million, versus the consensus of $39.23 million.
Orbitz Worldwide (NYSE: OWW) 10.9% HIGHER; reports Q1 loss of $4.08, which does not compare to the analyst estimate of ($0.16). Revenue for the quarter was $188 million, versus the consensus of $192.48 million.
Garmin (Nasdaq: GRMN) 10.8% LOWER; reports Q1 earnings of $0.25 per share, well below the consensus of $0.42. Revenues fell 34% $437 million, versus the consensus of $531.6 million.
Almost Family (Nasdaq: AFAM) 10.6% HIGHER; reports Q1 EPS of $0.68 adjusted, 8 cents better than the analyst estimate of $0.60. Revenue for the quarter was $62.9 million, versus the consensus of $63.03 million.
Kenneth Cole (NYSE: KCP) 10.6% LOWER; reports Q1 loss of $0.41, ex-items, 1 cent better than the analyst estimate of ($0.42). Revenue for the quarter fell 15.6% to $103.4 million, versus the consensus of $107.30 million.
Plantronics (NYSE: PLT) 10.2% HIGHER; reports Q1 adj-EPS of $0.01, versus the analyst estimate of ($0.16). Revenue for the quarter was $146.8 million, versus the consensus of $129.61 million. Declared a quarterly dividend of $0.05 per share.
Pitney Bowes Inc. (NYSE: PBI) 9.9% LOWER; reports Q1 EPS of $0.55, ex-items, 8 cents worse than the analyst estimate of $0.63. Revenue for the quarter was $1.38 billion, versus the consensus of $1.47 billion. The company expects adjusted earnings per diluted share from continuing operations for the year will be in the range of $2.40 to $2.60, versus the consensus of $2.63. The company is reaffirming its free cash flow guidance in the range of $700 million to $800 million for the year.
Bank of America (NYSE: BAC) 9% HIGHER; despite news that BofA will need another $35 billion in capital to cover "stress test" losses, the stock is surging on the back of a better-than-expected ADP report which showed a decline of less than 600,000 jobs for the first time in a while. The assumption is that if unemployment figures come in better than what was accounted for in the tests, BofA may not need further funds.
Foster Wheeler AG (Nasdaq: FWLT) 8.1% LOWER; reports Q1 EPS of $0.59, versus the analyst estimate of $0.68. Revenue for the quarter was $1.26 billion, versus the consensus of $1.51 billion.
Disney (NYSE: DIS) 7.1% HIGHER; reports Q2 EPS of $0.43, ex-items, 3 cents better than the analyst estimate of $0.40. Revenue for the quarter was $8.08 billion, versus the consensus of $8.15 billion.
Diana Shipping (NYSE: DSX) 6.7% HIGHER; reports Q1 earnings of $0.47 per share, above the consensus of $0.46. Revenues came in at $62.7 million, versus the consenus of $60.7 million.
Devon Energy (NYSE: DVN) 5.8% HIGHER; reports Q1 EPS of $0.48, ex-items, 20 cents better than the analyst estimate of $0.28. Revenue for the quarter was $2.028 billion, versus the consensus of $1.84 billion.
Get This Report Daily Here: http://www.streetinsider.com/entities/StreetInsider.com+Morning+Movers.
Acorda Therapeutics (Nasdaq: ACOR) 28.2% HIGHER; the FDA has accepted the Fampridine-SR New Drug Application for filing, assigning Priority Review and a Prescription Drug User Fee Act date of October 22, 2009. The PDUFA date is the target date for the FDA to complete its review of the Fampridine-SR NDA. Acorda also reported Q1 EPS of $0.50, 5 cents better than the analyst estimate of $0.55. Revenue for the quarter was $12.5 million, versus the consensus of $12.88 million.
ArvinMeritor (NYSE: ARM) 27% HIGHER; reports Q1 loss of $0.65, 3 cents better than the analyst estimate of ($0.68). Revenue for the quarter was $1.1 billion, versus the consensus of $1.24 billion. Click here for the full report.
Lincoln Educational Services (Nasdaq: LINC) 26.8% HIGHER; reports Q1 EPS of $0.22, versus the analyst estimate of $0.06. Revenue for the quarter was $118.6 million, versus the consensus of $112.25 million. Student starts increased by 42.4% as compared to Q108. On a same school basis, student starts increased 35.1% as compared to Q1. Sees Q2 EPS of $0.18-$0.20, on sales of $120-$122 million. The Street is currently looking for Q2 EPS and sales of $0.07 and $112.40 million, respectively. For the year, LINC sees EPS of $1.25-$1.30, versus the consensus of $0.95, with sales of $505-$515 million, which compares to the Street estimate of $482.04 million.
Maguire Properties (NYSE: MPG) 24.1% HIGHER; reports Q1 FFO loss of $0.64, compared to a loss of $0.01 in the same quarter last year. Revenue for the quarter was $ million, versus $ million in Q08.
ACCO Brands (NYSE: ABD) 22.2% LOWER; reports Q1 EPS of ($0.02), versus the analyst estimate of ($0.05). Revenue for the quarter was $293.4 million, versus the consensus of $332 million. Will not provide specific '09 guidance.
Bank of Ireland (NYSE: IRE) 20% HIGHER; European banks are outperforming today as investors continue to hang onto hopes that the worst could be behind us.
Cell Therapeutics (Nasdaq: CTIC) 19.1% HIGHER; following news yesterday that Cell Therapeutics' pixantrone is now available in Europe on a named-patient basis, momentum in the name is continuing today.
Par Pharma (NYSE: PRX) 19.1% HIGHER; reports Q1 EPS of $0.49, ex-items, versus the analyst estimate of $0.27. Revenue for the quarter was $204 million, versus the consensus of $170.23 million.
American Capital, Ltd. (Nasdaq: ACAS) 17.4% LOWER; reports Q1 EPS of $0.31, 6 cents worse than the analyst estimate of $0.37. Revenue for the quarter was $181 million, versus the consensus of $185.8 million.
American Medical Systems Holdings (Nasdaq: AMMD) 17.3% HIGHER; reports Q1 EPS of $0.25, 10 cents better than the analyst estimate of $0.15. Revenue for the quarter was $123.6 million, versus the consensus of $119.66 million. Company has increased its 2009 non-GAAP adjusted earnings per share guidance to a range of $0.96 to $1.07, from its earlier guidance of $0.86 to $0.99 per share. (Consensus is $0.80) The Company reiterates its full year 2009 revenue guidance in the range of $495 million to $515 million. (Consenus is $507.07M) Second quarter revenue is estimated in the range of $124 million to $130 million. (Consensus is $129.57M) The Company estimates second quarter 2009 non-GAAP adjusted earnings per share will be in the range of $0.22 to $0.26. (Consensus is $0.20)
Allied Irish Banks (NYSE: AIB) 16.6% HIGHER; see IRE.
Allis-Chalmers Energy Inc. (NYSE: ALY) 16.5% LOWER; reports Q1 loss of $0.07, 9 cents worse than the analyst estimate of $0.02. Revenue for the quarter was $145.1 million, versus the consensus of $151.10 million.
Fortress (NYSE: FIG) 15.2% HIGHER; reports Q1 loss of $0.71, versus the analyst estimate of ($0.05). Revenue for the quarter was $122.3 million, versus the consensus of $87.31 million.
Crocs (Nasdaq: CROX) 15.2% HIGHER; shares are continuing higher today following yesterday's 42% jump. Click here for the full report.
BigBand Networks (Nasdaq: BBND) 15% LOWER; reports Q1 EPS of $0.09, 4 cents better than the analyst estimate of $0.05. Revenue for the quarter was $43.9 million, versus the consensus of $44.29 million. For the second quarter of 2009 management provides the following outlook: Net revenues are expected to be in the range of $40 million to $42 million vs. consensus of $46.87 million. Non-GAAP net earnings per share are expected to be in the range of $0.02 to $0.04 vs. consensus of $0.06.
Boyd Gaming (NYSE: BYD) 14.9% HIGHER; reports Q1 earnings of $0.15 per share, ex-items, above the consensus of $0.08. Revenues fell 7.7% to $434.8 million, versus the consensus of $435.2 million.
Denny's Corporation (Nasdaq: DENN) 14.9% LOWER; reports Q1 EPS of $0.04, 1 cent worse than the analyst estimate of $0.05. Revenue for the quarter was $165.8 million, versus the consensus of $158.32 million. Based on year-to-date results and management’s expectations at this time, Denny’s is reaffirming its financial guidance for full-year 2009 as announced in its fourth quarter 2008 earnings release on February 18, 2009.
General Motors (NYSE: GM) 14.7% LOWER; downside related to the debt-to-equity swap and the possibly that the automaker could do a 1-for-100 reverse stock split.
Lincoln National (NYSE: LNC) 14.5% HIGHER; reports Q1 EPS of $0.66 including items, 5 cents below the analyst estimate of $0.71.
Biovail Corporation (NYSE: BVF) 13.6% LOWER; reports Q1 EPS of $0.42, 12 cents better than the analyst estimate of $0.30. Revenue for the quarter was $173.3 million, versus the consensus of $176.88 million. Biovail also announced today that it has entered into an agreement to acquire the U.S. commercialization rights to Wellbutrin XL(R) (extended-release bupropion hydrochloride tablets) from GlaxoSmithKline (GSK) for total consideration of $510 million. Also declared a quarterly dividend of $0.09 per share payable on July 6, 2009, to shareholders of record at the close of business May 15, 2009. The ex-dividend date is May 13, 2009. This represents a 76% reduction in the dividend payment.
True Religion Apparel (Nasdaq: TRLG) 12.3% HIGHER; reports Q1 EPS of $0.32, 4 cents better than the analyst estimate of $0.28. Revenue for the quarter rose 19.1% to $63.1 million, versus the consensus of $58.7 million. The Company is reiterating its guidance for the fiscal year ended December 31, 2009: Net sales are expected to be in the range of $290 million to $297 million, EPS is expected to be in the range of $1.73 to $1.81.
Rackable Systems, Inc. (Nasdaq: RACK) 11% LOWER; reports Q1 loss of $0.24, 9 cents worse than the analyst estimate of ($0.15). Revenue for the quarter was $44.4 million, versus the consensus of $39.23 million.
Orbitz Worldwide (NYSE: OWW) 10.9% HIGHER; reports Q1 loss of $4.08, which does not compare to the analyst estimate of ($0.16). Revenue for the quarter was $188 million, versus the consensus of $192.48 million.
Garmin (Nasdaq: GRMN) 10.8% LOWER; reports Q1 earnings of $0.25 per share, well below the consensus of $0.42. Revenues fell 34% $437 million, versus the consensus of $531.6 million.
Almost Family (Nasdaq: AFAM) 10.6% HIGHER; reports Q1 EPS of $0.68 adjusted, 8 cents better than the analyst estimate of $0.60. Revenue for the quarter was $62.9 million, versus the consensus of $63.03 million.
Kenneth Cole (NYSE: KCP) 10.6% LOWER; reports Q1 loss of $0.41, ex-items, 1 cent better than the analyst estimate of ($0.42). Revenue for the quarter fell 15.6% to $103.4 million, versus the consensus of $107.30 million.
Plantronics (NYSE: PLT) 10.2% HIGHER; reports Q1 adj-EPS of $0.01, versus the analyst estimate of ($0.16). Revenue for the quarter was $146.8 million, versus the consensus of $129.61 million. Declared a quarterly dividend of $0.05 per share.
Pitney Bowes Inc. (NYSE: PBI) 9.9% LOWER; reports Q1 EPS of $0.55, ex-items, 8 cents worse than the analyst estimate of $0.63. Revenue for the quarter was $1.38 billion, versus the consensus of $1.47 billion. The company expects adjusted earnings per diluted share from continuing operations for the year will be in the range of $2.40 to $2.60, versus the consensus of $2.63. The company is reaffirming its free cash flow guidance in the range of $700 million to $800 million for the year.
Bank of America (NYSE: BAC) 9% HIGHER; despite news that BofA will need another $35 billion in capital to cover "stress test" losses, the stock is surging on the back of a better-than-expected ADP report which showed a decline of less than 600,000 jobs for the first time in a while. The assumption is that if unemployment figures come in better than what was accounted for in the tests, BofA may not need further funds.
Foster Wheeler AG (Nasdaq: FWLT) 8.1% LOWER; reports Q1 EPS of $0.59, versus the analyst estimate of $0.68. Revenue for the quarter was $1.26 billion, versus the consensus of $1.51 billion.
Disney (NYSE: DIS) 7.1% HIGHER; reports Q2 EPS of $0.43, ex-items, 3 cents better than the analyst estimate of $0.40. Revenue for the quarter was $8.08 billion, versus the consensus of $8.15 billion.
Diana Shipping (NYSE: DSX) 6.7% HIGHER; reports Q1 earnings of $0.47 per share, above the consensus of $0.46. Revenues came in at $62.7 million, versus the consenus of $60.7 million.
Devon Energy (NYSE: DVN) 5.8% HIGHER; reports Q1 EPS of $0.48, ex-items, 20 cents better than the analyst estimate of $0.28. Revenue for the quarter was $2.028 billion, versus the consensus of $1.84 billion.
Get This Report Daily Here: http://www.streetinsider.com/entities/StreetInsider.com+Morning+Movers.
You May Also Be Interested In
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Chrysler LLC, Bank of America, Dividend, Morning Movers, BankruptcySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!

Up)